Lakewood-Amedex Enrolls First Patient in Phase 2 Clinical Trial for Patients with Chronic Diabetic Foot Ulcers (cDFU) ...Middle East

PR Newswire - News
Lakewood-Amedex Enrolls First Patient in Phase 2 Clinical Trial for Patients with Chronic Diabetic Foot Ulcers (cDFU)
Lakewood-Amedex's Second Clinical Trial for DFU Using New Nu-3 Gel Formulation Top Line Results Expected in December 2022 SARASOTA, Fla., April 5, 2022 /PRNewswire/ -- Lakewood-Amedex, Inc., a privately held, clinical stage pharmaceutical discovery and development company advancing a...

Read More Details
Finally We wish PressBee provided you with enough information of ( Lakewood-Amedex Enrolls First Patient in Phase 2 Clinical Trial for Patients with Chronic Diabetic Foot Ulcers (cDFU) )

Apple Storegoogle play

Also on site :